Holen Sie sich die Stockscreener-App
0.525
0.76%
-0.004
Handel nachbörslich:
.53
0.005
+0.95%
Schlusskurs vom Vortag:
$0.529
Offen:
$0.5146
24-Stunden-Volumen:
33,129
Relative Volume:
1.13
Marktkapitalisierung:
$3.36M
Einnahmen:
$1.10M
Nettoeinkommen (Verlust:
$-10.96M
KGV:
-0.256
EPS:
-2.0506
Netto-Cashflow:
$-7.01M
1W Leistung:
+7.14%
1M Leistung:
-18.34%
6M Leistung:
-72.37%
1J Leistung:
-9.48%
1-Tages-Spanne:
$0.5001
$0.543
1-Wochen-Bereich:
$0.48
$0.543
52-Wochen-Spanne:
$0.48
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.525 | 3.39M | 1.10M | -10.96M | -7.01M | -2.0506 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Sell Signal: Will Matinas BioPharma Holdings Inc benefit from government policy2026 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Aug Setups: Can Matinas BioPharma Holdings Inc generate free cash flow2026 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
Analyst Upgrade: Can Matinas BioPharma Holdings Inc ride the EV waveJobs Report & Real-Time Volume Analysis - baoquankhu1.vn
Aug Wrap: What are the risks of holding Matinas BioPharma Holdings Inc2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
SHPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Matinas BioPharma Receives NYSE American Non-Compliance Notice Due to Stockholders’ Equity and Ongoing Losses 1 - Minichart
SHPH PE Ratio & Valuation, Is SHPH Overvalued - Intellectia AI
Matinas BioPharma Faces NYSE Compliance Issues - Intellectia AI
Heritage Signs & Displays Completes JD Lewis Center Transformative Branding Project in Raleigh, NC - Weekly Voice
Matinas BioPharma Holdings, Inc. Notifies NYSE American of Non-Compliance with Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline - Stock Titan
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - ChartMill
Matinas BioPharma has until May 2 to answer NYSE notice - Stock Titan
MAT2203 stakes rise as Matinas BioPharma (NYSE: MTNB) slashes staff, seeks partner - Stock Titan
Gains Recap: What are the future prospects of Matinas BioPharma Holdings IncEarnings Performance Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Germany Stocks: Research Stocks from Germany Stock Market - GuruFocus
TOTDY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
DBSM.SI Should I Buy - Intellectia AI
Volume Recap: Will Matinas BioPharma Holdings Inc outperform tech stocks2026 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
BHAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MTNB PE Ratio & Valuation, Is MTNB Overvalued - Intellectia AI
Aug Update: Is Matinas BioPharma Holdings Inc a stock for growth or value investors2026 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
ES=F PE Ratio & Valuation, Is ES=F Overvalued - Intellectia AI
Performance Recap: What are the future prospects of Matinas BioPharma Holdings Inc2026 Momentum & Breakout Confirmation Trade Signals - baoquankhu1.vn
Volume Recap: Whats the beta of Matinas BioPharma Holdings Inc stockTrade Exit Report & Low Risk High Win Rate Picks - baoquankhu1.vn
MTNB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Dow Update: Can Matinas BioPharma Holdings Inc keep up with sector leaders2026 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
002044.SZ Forecast — Price Prediction for 2026. Should I Buy 002044.SZ? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CLF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving PremarketC3.ai - Benzinga
Gainers Report: How does ATHPRC correlate with NasdaqSwing Trade & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Can Matinas BioPharma Holdings Inc. ride the EV waveJuly 2025 Review & Risk Managed Trade Strategies - Mfd.ru
Is Matinas BioPharma Holdings Inc. a stock for growth or value investorsJuly 2025 Recap & Safe Capital Growth Tips - mfd.ru
Why Matinas BioPharma Holdings Inc. (6LJ0) stock is favored by hedge fundsWeekly Stock Report & High Accuracy Investment Signals - mfd.ru
Can Matinas Biopharma Holdings Inc. stock survive global slowdownWeekly Investment Report & Consistent Growth Stock Picks - mfd.ru
Entry Recap: Is Matinas BioPharma Holdings Inc exposed to currency risksJuly 2025 Catalysts & Weekly Breakout Watchlists - baoquankhu1.vn
What are the future prospects of Matinas BioPharma Holdings Inc.Trade Risk Summary & Smart Allocation Stock Tips - mfd.ru
What is Matinas BioPharma Holdings Inc. s P E ratio telling us2025 Biggest Moves & Safe Entry Zone Identification - mfd.ru
Can Matinas BioPharma Holdings Inc. stock outperform in 2025 bull market2025 Key Lessons & Weekly High Return Forecasts - mfd.ru
Merger Talk: Can Matinas BioPharma Holdings Inc ride the EV waveTrade Performance Summary & High Conviction Trade Alerts - baoquankhu1.vn
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO By Investing.com - Investing.com Nigeria
Matinas BioPharma CEO Named Interim Chief Financial Officer - The Globe and Mail
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO - Investing.com
Matinas BioPharma Holdings Inc Keith Kucinski resigns as CFO effective January 17, 2026 - marketscreener.com
Buyback Watch: Is STNG undervalued by DCF analysisBuy Signal & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026 - TradingView
Trend Report: Is Matinas BioPharma Holdings Inc stock heavily shortedNew Guidance & Weekly High Conviction Ideas - baoquankhu1.vn
Valuation Update: What is CRVSs book value per share2025 Year in Review & Daily Market Momentum Tracking - baoquankhu1.vn
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):